Publikasi

Media Choice Significantly Affects Commercial MSC Produ...

Five basal and serum-free media used to produce mesenchymal stem cells were anal...

Plug-and-Play Future for Personalized T-Cell Cancer The...

A new automated TCR-T manufacturing system streamlines activation, engineering, ...

Novel AI Drug Toxicity Models to Improve Drug Safety to...

The industrial-academic partnership has the potential to reduce late-stage devel...

Scientists Calibrate Raman Spectroscopy without Running...

Scientists from the Netherlands have used single compounds to speed up Raman spe...

Psychiatry breakthrough: Genetic mapping reveals five k...

Het bericht Psychiatry breakthrough: Genetic mapping reveals five key factors un...

Cytiva and Fida Biosystems Combine Technologies to Expa...

By linking structural details, such as protein size and stability, with binding ...

Integrated Continuous Precision Fermentation Platform R...

Unlike traditional fermentation approaches that rely on batch or fed-batch proce...

Cipla launches Yurpeak (tirzepatide) for obesity and ty...

Company to distribute and promote the once-weekly injectable therapy following ...

Charlotte emerging as a global leader in health care in...

Historically, Charlotte has been recognized as a major U.S. financial hub. Now, ...

Formycon and Zydus sign exclusive agreement for FYB206 ...

Formycon will complete the development of FYB206, prepare and file the regulator...

Health Canada approves Biogen’s Zurzuvae for PPD treatment

The once-daily oral therapy is administered as a 14-day course. Clinical trials ...

Servier India secures CDSCO approval for Vorasidenib fo...

Approval enables access to targeted therapy for adults and adolescents aged 12 ...

Pharmacists can be true changemakers in population health

Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Ku...

USC India Awards honours Kiran Mazumdar-Shaw with Busin...

Biocon Group Chairperson recognised in Mumbai ceremony for contributions to gl...

Zydus Lifesciences signs licensing deal with Formycon

Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lif...

GNPS Drug Library Uncovers Drug Exposures Using Untarge...

Researchers say comparing unknown compounds in a patient’s blood or urine to tho...